Results 151 to 160 of about 8,658 (209)
Some of the next articles are maybe not open access.

Myxedema Coma

Journal of Intensive Care Medicine, 2007
Untreated or unrecognized hypothyroidism may progress to severe decompensated hypothyroidism or myxedema coma. Relatively few cases are reported in the literature since the first case was apparently reported from the St. Thomas Hospital in London in 1879.
Kenneth Burman
exaly   +3 more sources

Myxedema Madness – Systematic literature review of published case reports

General Hospital Psychiatry, 2021
Maria C Jockers-Scherübl
exaly   +2 more sources

Utility of myxedema score as a predictor of mortality in myxedema coma

Journal of Endocrinological Investigation, 2022
Naresh Sachdeva, Anil Bhansali
exaly   +2 more sources

Myxedema Coma Precipitated by Iohexol: Case Report and Brief Literature Review on the Wolff–Chaikoff Effect

Thyroid, 2022
Background: Failure to escape from the Wolff–Chaikoff effect (WCE) causes hypothyroidism. Methods: This is the first report of myxedema coma after iohexol administration.
Eng-Loon Tng
exaly   +2 more sources

Myxedema coma in children and adolescents: A rare endocrine emergency - Personal experience and review of literature

Acta bio-medica : Atenei Parmensis, 2021
Decompensated hypothyroidism, formerly known as myxedema coma, represents the most extreme clinical expression of severe primary or secondary hypothyroidism in which patients exhibit multiple organ abnormalities and progressive mental deterioration.
V. De Sanctis   +7 more
semanticscholar   +1 more source

Periorbital Myxedema

Journal of Osteopathic Medicine, 2016
Jimmy Tam Huy Pham
exaly   +3 more sources

Clinical Features and Outcomes of Myxedema Coma in Patients Hospitalized for Hypothyroidism: Analysis of the United States National Inpatient Sample

Thyroid
Background: Hypothyroidism is a common endocrine condition and chronic thyroid hormone deficiency is associated with adverse effects across multiple organ systems.
Trevor E Angell
exaly   +2 more sources

Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case Series

Thyroid, 2019
Background: Severe pretibial myxedema (PTM) can be difficult to manage, highlighting the need to investigate newer therapies. Rituximab (RTX) and intravenous immunoglobulin (IVIg) have been tried in Graves' orbitopathy.
Mark Pittelkow   +2 more
exaly   +2 more sources

Myxedema coma

Annals of Emergency Medicine, 1982
S, Hamburger, R E, Collier
exaly   +3 more sources

Erythrokinetics in Myxedema

Annals of Internal Medicine, 1967
Excerpt Normochromic anemia of modest degree is common in myxedematous patients and may persist for months after institution of thyroid hormone therapy (1-3).
J M, Kiely, D C, Purnell, C A, Owen
openaire   +2 more sources

Home - About - Disclaimer - Privacy